Analysis of the Household and Health Care System Expenditures in Bulgaria
Bibliographic Data
| ID | 22077108 |
|---|---|
| Authors | Zornitsa Mitkova (0000-0003-0782-200X, Medical University of Sofia, corresponding author), Guenka Petrova (0000-0001-8116-5138, Medical University of Sofia) |
| Year | 2021 |
| Volume | 9 |
| Pages | 675277-675277 |
| Publication date | 2021-07-02 |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | Frontiers in Public Health (JOURNAL) |
| Journal identifiers | ISSN: 2296-2565 • E-ISSN: 2296-2565 |
| Publisher | Frontiers Media SA (PUBLISHER • CH) |
| DOI | 10.3389/fpubh.2021.675277 |
| PMID | 34277542 |
| OpenAlex | W3186992732 |
| Language | EN |
| Citations received | 1 |
| References cited | 12 |
Health care systems worldwide are experiencing tremendous financial pressure because of the introduction of new targeted health technologies and medicines. This study aims to analyze and compare public and household healthcare expenditures in Bulgaria during the period 2015–2019, as well as present the major cost-containment measures implied by the government and their probable influence on the overall health care cost. Regulatory analysis of the endorsed cost-containment measures, budget analysis of public and household health care expenditures, and their extrapolations were performed. The regulatory analysis reveals that a large number of measures are introduced and valid until January 2021, considering pharmaceuticals, medical devices, and negotiations between the National Health Insurance Fund (NHIF) and Marketing authorization holders (MAHs). NHIF costs due to pharmaceuticals, food supplements, and medical devices are rising from 2015 to 2019. The overall health expenditures average per household and the average per person also grow in this period. The cost extrapolation reveals that an increase in 3-year periods is expected. Despite the implementation of variety of cost-containment measures in Bulgaria, such as HTA, ERP, discounts, and annual negotiations, The National Health Insurance Fund's (NHIF) spending on pharmaceuticals continues to rise in recent years, and further increases are expected in the next 3 years. The average expenditure per household and per person also increased, which confirms the global trend of rising medicine and outpatient services value
Business · Economic growth · Economics · Environmental health · Health care · Negotiation · Public economics · Public health · Global Health Care Issues · Health Systems, Economic Evaluations, Quality of Life · Healthcare Systems and Reforms · Medicine
| Citations per year | 0.25 |
|---|---|
| Citation span | 2022 - 2022 (1) |
| Highly cited | No |